MacKenzie Realty Capital, Inc. (MKZR)
NASDAQ: MKZR · Real-Time Price · USD
5.18
-0.32 (-5.82%)
Oct 24, 2025, 4:00 PM EDT - Market closed
Company Description
MacKenzie, founded in 2013, is a West Coast-focused REIT that intends to invest at least 80% of its total assets in real property, and up to a maximum of 20% of its total assets in illiquid real estate securities.
We intend for the real property portfolio to be approximately 50% multifamily and 50% boutique class A office.
The Company has paid a dividend every year since inception. The current portfolio includes interests in 4 multifamily properties and 8 office properties plus 2 multifamily developments.
MacKenzie Realty Capital, Inc.
| Country | United States |
| Founded | 2012 |
| Industry | REIT - Diversified |
| Sector | Real Estate |
| CEO | Robert Dixon |
Contact Details
Address: 89 Davis Road, Suite 100 Orinda, California 94563 United States | |
| Phone | 925 631 9100 |
| Website | mackenzierealty.com |
Stock Details
| Ticker Symbol | MKZR |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | July - June |
| Reporting Currency | USD |
| CIK Code | 0001550913 |
| CUSIP Number | 55453W501 |
| ISIN Number | US55453W5013 |
| Employer ID | 45-4355424 |
| SIC Code | 6798 |
Key Executives
| Name | Position |
|---|---|
| Robert E. Dixon C.F.A. | Chief Executive Officer and President |
| Charles Evans Patterson II | Chairman, General Counsel and Secretary |
| Angche Sherpa | Chief Financial Officer and Treasurer |
| Glen William Fuller | Chief Operating Officer |
| Jeri Ruth Bluth | Chief Compliance Officer |
| Christine Elizabeth Simpson | Chief Portfolio Manager |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Oct 23, 2025 | 1-A POS | Filing |
| Oct 14, 2025 | 8-K | Current Report |
| Oct 14, 2025 | 8-K | Current Report |
| Oct 6, 2025 | SCHEDULE 13D/A | Filing |
| Sep 30, 2025 | 8-K | Current Report |
| Sep 30, 2025 | DEF 14A | Other definitive proxy statements |
| Sep 29, 2025 | 10-K | Annual Report |
| Aug 22, 2025 | 8-K | Current Report |
| Aug 21, 2025 | SCHEDULE 13D | Filing |
| Aug 14, 2025 | SCHEDULE 13G/A | Filing |